DUBLIN–(BUSINESS WIRE)–The Report “Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End User, By Region; Segment Forecast, 2022-2030 ” has been added to the report from ResearchAndMarkets.com offer.
The global lymphedema treatment market size is expected to reach USD 1,735.36 million by 2030 according to a new study. The report provides a detailed overview of current market dynamics and provides analysis of future market growth.
AIROS Medical Inc.
Avet Pharmaceuticals Inc.
Essity (BSN medical GmbH)
Huntleigh Healthcare Limited
Lohmann & Rauscher
Mego Afek Ltd.
Smith+Neveu HERANTIS PHARMA Plc
The increasing number of people affected by lymphedema is expected to drive the growth of the lymphedema cure industry. Additionally, with the increasing prevalence of the disease, innovative and advanced treatments are being developed to minimize the risks during recovery. Additionally, increasing healthcare expenditures coupled with growing innovation in the healthcare sector is expected to further boost the growth of the industry. Additionally, the launch of new medical devices by pharmaceutical companies is also fueling the growth of the industry across the globe.
On the basis of type, the Secondary Lymphedema segment is dominating the global industry and is expected to lead the industry during the forecast period. Secondary lymphedema is usually caused by damage to the lymphatic system from cancer treatment with radiation therapy and surgery, among other things. According to the CDC (Centers for Disease Control & Prevention), the majority of patients suffer from secondary lymphedema. Thus, the presence of a large pool of patients is expected to drive the growth of the segment.
Growing investment by government and private pharmaceutical companies in R&D for drug discovery is expected to present huge growth opportunities for the industry. Additionally, the rising prevalence of cancer and other chronic diseases is expected to drive the growth of the industry. For example, according to the International Agency for Research on Cancer (IARC), in 2018 nearly 17.0 million new cancer cases were recorded, which is expected to reach 27.5 million new cancer cases by 2040 due to population growth and aging. population. Thus, the growing incidence of cancer further acts as a catalyzing factor for the growth of the market.
Main topics covered:
2. Executive Summary
3. Research methodology
4. Global Lymphedema Treatment Market Overview
4.1. Lymphedema Treatment – Industry Overview
4.2. Lymphedema Treatment Market Dynamics
4.2.1. Drivers and opportunities
220.127.116.11. Prevalence of lymphedema and cancer
18.104.22.168. Technological Advances in Diagnostic Imaging Modalities
4.2.2. Constraints and challenges
22.214.171.124. Short half-life of radiopharmaceuticals
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining power of suppliers (moderate)
4.3.2. Threats from new entrants: (low)
4.3.3. Bargaining power of buyers (moderate)
4.3.4. Substitute Threat (Moderate)
4.3.5. Rivalry between existing companies (high)
4.4. PESTEL analysis
4.5. Lymphedema Treatment Market Trends
4.6. Value chain analysis
4.7. COVID-19 Impact Analysis
5. Global Lymphedema Treatment Market, By Treatment Type
6. Global Lymphedema Treatment Market, By Affected Area
7. Global Lymphedema Treatment Market, By End Use
8. Global Lymphedema Treatment Market, By Geography
9. Competitive landscape
9.1. Expansion and acquisition analysis
10. Company Profiles
For more information about this report, visit https://www.researchandmarkets.com/r/nq4dyf.